Fluorescent Gold Nanoclusters for Selective Detection of Dopamine in Cerebrospinal fluid

Saravanan Govindaraju,Seshadri Reddy Ankireddy,Buddolla Viswanath,Jongsung Kim,Kyusik Yun

DOI: https://doi.org/10.1038/srep40298

IF: 4.6

2017-01-09

Scientific Reports

Abstract:Since the last two decades, protein conjugated fluorescent gold nanoclusters (NCs) owe much attention in the field of medical and nanobiotechnology due to their excellent photo stability characteristics. In this paper, we reported stable, nontoxic and red fluorescent emission BSA-Au NCs for selective detection of L-dopamine (DA) in cerebrospinal fluid (CSF). The evolution was probed by various instrumental techniques such as UV-vis spectroscopy, High resolution transmission electron microscopy (HTEM), X-ray photoelectron spectroscopy (XPS), X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR), photoluminescence spectroscopy (PL). The synthesised BSA-Au NCs were showing 4–6 nm with high fluorescent ~8% Quantum yield (QY). The fluorescence intensity of BSA-Au NCs was quenched upon the addition of various concentrations of DA via an electron transfer mechanism. The decrease in BSA-Au NCs fluorescence intensity made it possible to determine DA in PBS buffer and the spiked DA in CSF in the linear range from 0 to 10 nM with the limit of detection (LOD) 0.622 and 0.830 nM respectively. Best of our knowledge, as-prepared BSA-Au NCs will gain possible strategy and good platform for biosensor, drug discovery, and rapid disease diagnosis such as Parkinson’s and Alzheimer diseases.

multidisciplinary sciences

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the selective detection of dopamine (L - dopamine, DA) in cerebrospinal fluid (CSF). Dopamine is an important neurotransmitter, belonging to the catecholamine family, and plays a crucial role in nervous system functions such as motor control, emotion, and memory. Abnormal or insufficient dopamine levels are associated with a variety of neurological diseases, especially Parkinson's disease and Alzheimer's disease. Therefore, the ability to accurately and rapidly detect dopamine is of great significance for the diagnosis and treatment of diseases.

The paper introduced a new type of fluorescent gold nanoclusters (BSA - Au NCs). These nanoclusters are protected by bovine serum albumin (BSA) and can selectively detect dopamine in CSF through a fluorescence quenching mechanism. The research verified the synthesis, structure, and properties of BSA - Au NCs through a variety of technical means, such as ultraviolet - visible spectroscopy (UV - vis), high - resolution transmission electron microscopy (HRTEM), X - ray photoelectron spectroscopy (XPS), X - ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR), and photoluminescence spectroscopy (PL), etc. The experimental results show that the linear detection range of BSA - Au NCs in PBS buffer and spiked CSF is from 0 to 10 nM, and the limits of detection (LOD) are 0.622 nM and 0.830 nM respectively, showing high sensitivity and selectivity.

In conclusion, this research has developed an environmentally friendly, low - cost, and efficient dopamine detection method, providing a new platform for biosensing, drug discovery, and rapid disease diagnosis.